NEW YORK (GenomeWeb) – PathGroup and Cancer Clinics of Excellence today announced a partnership aimed at improving the ability of community-based oncologists to make personalized therapeutic decisions.

CCE has chosen PathGroup as a preferred laboratory service provider, and oncologists in CCE's network will now have access to tests and data generated by PathGroup using its SmartGenomics platform, which generates information about patient drug targets so physicians can make more precise, personalized therapeutic recommendations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.